Skip to content
10-K

Annual Report

Biohaven Pharmaceutical Holding Company Ltd.

0001689813-22-000014

← back to feed
Filed
Feb 25, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Feb 21, 2022 70.52M sh
Shares Diluted FY 2021 · Dec 31, 2021 64.68M sh
Shares Diluted FY 2021 · Dec 31, 2020 58.73M sh
Shares Diluted FY 2021 · Dec 31, 2019 48.49M sh
Capex FY 2021 · Dec 31, 2021 $1.72M
Capex FY 2021 · Dec 31, 2020 $2.37M
Capex FY 2021 · Dec 31, 2019 $2.53M
Operating Cash Flow FY 2021 · Dec 31, 2021 −$831.1M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$702.88M
Operating Cash Flow FY 2021 · Dec 31, 2019 −$377.33M
Cash And Equivalents FY 2021 · Dec 31, 2021 $171.95M
Cash And Equivalents FY 2021 · Dec 31, 2020 $132.15M
Cash And Equivalents FY 2021 · Dec 31, 2019 $316.73M
Stockholders Equity FY 2021 · Dec 31, 2021 −$739.38M
Stockholders Equity FY 2021 · Dec 31, 2020 −$390.37M
Current Liabilities FY 2021 · Dec 31, 2021 $534.2M
Current Liabilities restated FY 2021 · Dec 31, 2020 $277.61M
Total Liabilities FY 2021 · Dec 31, 2021 $1.76B
Total Liabilities FY 2021 · Dec 31, 2020 $1.02B
Current Assets FY 2021 · Dec 31, 2021 $876.25M
Current Assets FY 2021 · Dec 31, 2020 $603.41M
Total Assets FY 2021 · Dec 31, 2021 $1.08B
Total Assets FY 2021 · Dec 31, 2020 $686.98M
Eps Diluted FY 2021 · Dec 31, 2021 −$13.09
Eps Diluted FY 2021 · Dec 31, 2020 −$13.06
Eps Diluted FY 2021 · Dec 31, 2019 −$10.91
Eps Basic FY 2021 · Dec 31, 2021 −$13.09
Eps Basic FY 2021 · Dec 31, 2020 −$13.06
Eps Basic FY 2021 · Dec 31, 2019 −$10.91
Sga Expense FY 2021 · Dec 31, 2021 $713.55M
Sga Expense FY 2021 · Dec 31, 2020 $462.32M
Sga Expense FY 2021 · Dec 31, 2019 $134.45M
Rd Expense FY 2021 · Dec 31, 2021 $361.34M
Rd Expense FY 2021 · Dec 31, 2020 $229M
Rd Expense FY 2021 · Dec 31, 2019 $344.67M
Net Income FY 2021 · Dec 31, 2021 −$846.59M
Net Income FY 2021 · Dec 31, 2020 −$766.8M
Net Income FY 2021 · Dec 31, 2019 −$528.81M
Operating Income FY 2021 · Dec 31, 2021 −$704.04M
Operating Income FY 2021 · Dec 31, 2020 −$645.39M
Operating Income FY 2021 · Dec 31, 2019 −$479.12M
Gross Profit FY 2021 · Dec 31, 2021 $370.85M
Gross Profit FY 2021 · Dec 31, 2020 $45.93M
Gross Profit FY 2021 · Dec 31, 2019 $0
Cost Of Revenue FY 2021 · Dec 31, 2021 $91.66M
Cost Of Revenue FY 2021 · Dec 31, 2020 $17.69M
Cost Of Revenue FY 2021 · Dec 31, 2019 $0
Revenue FY 2021 · Dec 31, 2021 $462.51M
Revenue FY 2021 · Dec 31, 2020 $63.63M
Revenue FY 2021 · Dec 31, 2019 $0